Haematology is the branch of laboratory medicine that focuses on the study, diagnosis, and management of blood disorders, including abnormalities in red blood cells, white blood cells, platelets, bone marrow, and coagulation systems. Flow cytometry is a powerful technology often integrated with hematology to analyze the physical and chemical characteristics of blood cells, enabling rapid, precise, and detailed assessment of hematologic conditions.

Haematology encompasses tests such as complete blood counts (CBC), peripheral blood smear examination, coagulation studies, bone marrow analysis, and specialised assays for hemoglobinopathies, anaemia, leukaemia, lymphomas, and clotting disorders. These tests help identify infections, blood cancers, bleeding disorders, and immune deficiencies, as well as monitor disease progression and treatment response.

Flow cytometry allows simultaneous multiparametric analysis of individual cells by labelling them with fluorescent markers. It is widely used for immunophenotyping of leukaemias and lymphomas, detecting minimal residual disease, assessing immune system status, and identifying specific cell populations in complex disorders. This technology enhances diagnostic accuracy and guides personalised treatment strategies.

Blood or bone marrow samples are collected under standardised protocols and processed in the laboratory. Haematologists and laboratory specialists interpret results, integrating them with clinical findings to provide comprehensive diagnostic and prognostic information. Flow cytometry provides rapid, quantitative, and highly sensitive detection of abnormal or malignant cells. By combining conventional haematology with advanced flow cytometry, this service offers precise diagnosis, treatment planning, and monitoring for a wide range of blood disorders. It plays a crucial role in early detection of hematologic malignancies, guiding therapy, and improving patient outcomes, making it an indispensable component of modern clinical medicine.